| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef499e33356a62c3e006fafaf49c72a3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2011-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ca1fa145e06b6f95111b87ab396c7d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb42631d0e0e33d938796f9e1fa38bbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f45047c439183de9bc5fac688dc44ecb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5a7767677a5004e273096e2688834a4 |
| publicationDate |
2013-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2637691-A2 |
| titleOfInvention |
Materials and methods for directing an immune response to an epitope |
| abstract |
The present invention relates to compositions, kits, and methods useful for directing an immune response to an epitope of an antigen in a subject, by sensitizing the subject to the epitope and/or by tolerizing the subject to the epitope. The sensitizing method comprises co-administering to the subject the epitope and an immunoglobulin M (IgM) constant region (IgM Fc region). The tolerizing method comprises co-administering to the subject the epitope and an immunoglobulin G (IgG) constant region (IgG Fc region) to the subject. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10800849-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11447557-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10155818-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10280226-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10577426-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11401335-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10836830-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11359028-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10829559-B2 |
| priorityDate |
2010-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |